233 related articles for article (PubMed ID: 1310767)
1. Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles.
Schubert M; Joshi B; Blondel D; Harmison GG
J Virol; 1992 Mar; 66(3):1579-89. PubMed ID: 1310767
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
Johnson JE; Schnell MJ; Buonocore L; Rose JK
J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
Owens RJ; Rose JK
J Virol; 1993 Jan; 67(1):360-5. PubMed ID: 8093220
[TBL] [Abstract][Full Text] [Related]
4. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
[TBL] [Abstract][Full Text] [Related]
5. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
Haglund K; Forman J; Kräusslich HG; Rose JK
Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
[TBL] [Abstract][Full Text] [Related]
6. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
Broder CC; Berger EA
J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
Vincent MJ; Raja NU; Jabbar MA
J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
[TBL] [Abstract][Full Text] [Related]
8. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles.
Dalton KP; Rose JK
Virology; 2001 Jan; 279(2):414-21. PubMed ID: 11162797
[TBL] [Abstract][Full Text] [Related]
9. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.
Kretzschmar E; Buonocore L; Schnell MJ; Rose JK
J Virol; 1997 Aug; 71(8):5982-9. PubMed ID: 9223488
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.
Keil W; Wagner RR
Virology; 1989 Jun; 170(2):392-407. PubMed ID: 2471352
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1.
Rose NF; Roberts A; Buonocore L; Rose JK
J Virol; 2000 Dec; 74(23):10903-10. PubMed ID: 11069984
[TBL] [Abstract][Full Text] [Related]
12. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein.
Whitt MA; Buonocore L; Prehaud C; Rose JK
Virology; 1991 Dec; 185(2):681-8. PubMed ID: 1660200
[TBL] [Abstract][Full Text] [Related]
13. Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.
Lefkowitz EJ; Pattnaik AK; Ball LA
Virology; 1990 Oct; 178(2):373-83. PubMed ID: 2171187
[TBL] [Abstract][Full Text] [Related]
14. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway.
Boritz E; Gerlach J; Johnson JE; Rose JK
J Virol; 1999 Aug; 73(8):6937-45. PubMed ID: 10400792
[TBL] [Abstract][Full Text] [Related]
15. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
Nussbaum O; Broder CC; Berger EA
J Virol; 1994 Sep; 68(9):5411-22. PubMed ID: 8057423
[TBL] [Abstract][Full Text] [Related]
16. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
Johnson JE; Rodgers W; Rose JK
Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
[TBL] [Abstract][Full Text] [Related]
17. Elicitation of neutralizing antibodies by intranasal administration of recombinant vesicular stomatitis virus expressing human immunodeficiency virus type 1 gp120.
Jiang P; Liu Y; Yin X; Yuan F; Nie Y; Luo M; Aihua Z; Liyin D; Ding M; Deng H
Biochem Biophys Res Commun; 2006 Jan; 339(2):526-32. PubMed ID: 16313884
[TBL] [Abstract][Full Text] [Related]
18. Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.
Pattnaik AK; Wertz GW
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1379-83. PubMed ID: 1847519
[TBL] [Abstract][Full Text] [Related]
19. Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.
Golding H; Blumenthal R; Manischewitz J; Littman DR; Dimitrov DS
J Virol; 1993 Nov; 67(11):6469-75. PubMed ID: 8411350
[TBL] [Abstract][Full Text] [Related]
20. The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.
Robison CS; Whitt MA
J Virol; 2000 Mar; 74(5):2239-46. PubMed ID: 10666254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
